Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01618968 · ClinicalTrials.gov registry record · Phase 2

Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device

A Phase 2 study of Rheumatoid Arthritis (RA), sponsored by Antares Pharma.

Completed
Registry status
Phase 2
Development phase
49
Enrollment target
1
Study location

NCT01618968 is a Phase 2 study of Rheumatoid Arthritis (RA) that has completed, run by Antares Pharma. The registered enrollment target is 49 participants, below the 265-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01618968, a Phase 2 study of Rheumatoid Arthritis (RA), has completed, sponsored by Antares Pharma.

COMPLETED
Registry status
Phase 2
Development phase
49 participants
Enrollment target
1
Study location

Study Summary

Relative Bioavailability Comparison study

Conditions Studied

Rheumatoid Arthritis (RA)

Interventions

  • DRUG MTX

Study Locations (1)

Pennsylvania

  • Altoona Center for Clinical Research - Duncansville

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2012-05
Est. Completion 2012-08
Phase Phase 2

Sponsor

Antares Pharma

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01618968

The ClinicalTrials.gov registry entry for NCT01618968 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 265-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (82% lower). The listed sponsor is Antares Pharma, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis (RA) appearing as the primary indexed condition, and to 1 intervention - of which MTX is the first listed.

NCT01618968 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01618968 about?

NCT01618968 is a clinical study titled "Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device". Relative Bioavailability Comparison study

What is the current status of trial NCT01618968?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2012-05. Estimated completion is 2012-08.

What conditions does trial NCT01618968 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis (RA).

What interventions are being tested in trial NCT01618968?

The interventions under investigation include: MTX (DRUG).

Who is sponsoring clinical trial NCT01618968?

This trial is sponsored by Antares Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01618968 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis (RA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis (RA)

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.